Neutrophil–lymphocyte ratio, platelet–lymphocyte ratio, neutrophil–platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?

References

• Kos FT, Hocazade C, Kos M, et al. Assessment of prognostic value of “neutrophil to lymphocyte ratio” and “prognostic nutritional index” as a systemic inflammatory marker in non-small cell lung cancer. Asian Pac J Cancer Prev 2015;16:3997-4002
   PubMedGoogle Scholar
• Sun K, Chen S, Xu J, et al. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. J Cancer Res Clin Oncol 2014;140:1537-49
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to virchow? Lancet 2001;357:539-45
   PubMed Web of Science ®Google Scholar
• Watt DG, Proctor MJ, Park JH, et al. The neutrophil–platelet score (NPS) predicts survival in primary operable colorectal cancer and a variety of common cancers. PLoS One 2015;10:e0142159
   PubMed Web of Science ®Google Scholar
• Dogan M, Eren T, Ozdemir N, et al. The relationship between platelet–lymphocyte ratio, neutrophil–lymphocyte ratio, and survival in metastatic gastric cancer on firstline modified docetaxel and cisplatinum plus 5 fluorourasil regimen: a single institute experience. Saudi J Gastroenterol 2015;21:320-4
   PubMed Web of Science ®Google Scholar
• Nozoe T, Kimura Y, Ishida M, et al. Correlation of preoperative nutritional condition with postoperative complications in surgical treatment for oesophageal carcinoma. Eur J Surg Oncol 2002;28:396-400
   PubMed Web of Science ®Google Scholar
• Pinato DJ, North BV, Sharma R. A novel, externally validated inflammation based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br J Cancer 2012;106:1439-45
   PubMed Web of Science ®Google Scholar
• Unal D, Eroglu C, Kurtul N, et al. Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non-small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev 2013;14:5237-42
   PubMed Web of Science ®Google Scholar
• Jin H, Zhang G, Liu X, et al. Blood neutrophil–lymphocyte ratio predicts survival for stages III–IV gastric cancer treated with neoadjuvant chemotherapy. World J Surg Oncol 2013;11:112-21
   PubMed Web of Science ®Google Scholar
• Montavani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008;454:436-44
   PubMed Web of Science ®Google Scholar
• Aliustaoglu M, Bilici A, Seker M, et al. The association of pretreatment peripheral blood markers with survival in patients with pancreatic cancer. Hepatogastroenterology 2010;57:640-5
   PubMedGoogle Scholar
• Jain S, Gautam V, Naseem S. Acute-phase proteins: as diagnostic tool. J Pharm Bioallied Sci 2011;3:118-27
   PubMedGoogle Scholar
• Yang Y, Gao P, Song Y, et al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur J Surg Oncol 2016;42:1176-82
   PubMed Web of Science ®Google Scholar
• Migita K, Takayama T, Saeki K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage. Ann Surg Oncol 2013;20:2647-54
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30
   PubMed Web of Science ®Google Scholar
• Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi 1984;85:1001-5
   PubMedGoogle Scholar
• Ballehaninna UK, Chamberlain RS. Serum CA 19-9 as a biomarker for pancreatic cancer – a comprehensive review. Indian J Surg Oncol 2011;2:88-100
   PubMedGoogle Scholar
• Safi F, Roscher R, Bittner R, et al. High sensitivity and specificity of CA 19-9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings. Pancreas 1987;2:398-403
   PubMed Web of Science ®Google Scholar
• Hess V, Glimelius B, Grawe P, et al. CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. Lancet Oncol 2008;9:132-8
   PubMed Web of Science ®Google Scholar
• Yildirim M, Yildiz M, Duman E, et al. Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer. J BUON 2013;18:728-32
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7
   PubMed Web of Science ®Google Scholar
• Wang DS, Luo HY, Qiu MZ, et al. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer. Med Oncol 2012;29:3092-100
   PubMed Web of Science ®Google Scholar
• Azab B, Shah N, Radbel J, et al. Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients. Med Oncol 2013;30:432
   PubMed Web of Science ®Google Scholar
• Jin J, Hu K, Zhou Y, et al. Prognostic value of the Glasgow prognostic score in lung cancer: evidence from 10 studies. Int J Biol Markers 2017: published online 24 October 2017, doi: 10.5301/ijbm.5000308
   Web of Science ®Google Scholar
• Nozoe T, Matono R, Ijichi H, et al. Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma. Int Surg 2014;99:512-17
   PubMed Web of Science ®Google Scholar
• McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience inpatients with cancer. Cancer Treat Rev 2013;39:534-40
   PubMed Web of Science ®Google Scholar
• Otowa Y, Nakamura T, Takiguchi G, et al. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer. Dis Esophagus 2016;29:146-51
   PubMed Web of Science ®Google Scholar
• Yao ZH, Tian GY, Wan YY, et al. Prognostic nutritional index predicts outcomes of malignant pleural mesothelioma. J Cancer Res Clin Oncol 2013;139:2117-23
   PubMed Web of Science ®Google Scholar
• Mantzorou M, Koutelidakis A, Theocharis S, et al. Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? Nutr Cancer 2017;69:1151-76.
   PubMed Web of Science ®Google Scholar
• Grigorian A, O’Brien CB. Hepatotoxicity secondary to chemotherapy. J Clin Transl Hepatol 2014;2:95-102
   PubMedGoogle Scholar